← All stocks

Century Therapeutics, Inc.

IPSC Net buying
CIK 0001850119 #3356 in the set updated 17 Sep 2026
Bought (12 mo)
$96.93K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$86.19K
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$86.19K
20 of 20 sales
Net
+$10.75K
+$10.75K against sales at will

By person

6 insiders · 23 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Cowan Chad
Chief Scientific Officer
$49.25K (1)
$2.74K (1)
+$46.52K
1,175,322
$2.27M
+763.8%
Russotti Gregory
See Remarks
$40.14K (7)
−$40.14K
601,971
$1.16M
+63.7%
Pfeiffenberger Brent
President and CEO
$47.68K (2)
$14.74K (1)
+$32.95K
3,633,839
$7.01M
+144.8%
Carr Douglas
SVP Finance & Operations
$28.58K (11)
−$28.58K
502,907
$970.61K
+50.6%
Farid Adrienne
Chief Operations Officer
250,141
$482.77K
+83.7%
Conn Morgan
Chief Finanical Officer
79,648
$153.72K

No percentages here. This company's share count has moved by a factor of 2.1 over the window, from 85,029,042 to 181,075,321 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Cowan Chad
22 Dec 2025
Chief Scientific Officer
Buy
58,060
$0.85
$49.25K
Pfeiffenberger Brent
12 Dec 2025
President and CEO
Buy
52,000
$0.58
$30.35K
Pfeiffenberger Brent
19 Nov 2025
President and CEO
Buy
35,000
$0.50
$17.33K

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 20
Transactions with no price 0
Shares from compensation/vesting 1,800,772
History held since 21 Jun 2021